EUVIMEDEUVIMED entdecken
Crossref

Oral Colchicine and Low-Dose Aspirin Combination Therapy for Non-elderly, Non-severe, Early Time From Onset, Adult Outpatients with Coronavirus Disease 2019 (COVID-19) during “The Fifth Pandemic Wave” in Japan

Tetsuaki Inokuchi, Tomoki Homma, Yasuhiko Kitasato, Mayu Akiyama, Ayako Chikasue, Yuuya Nishii, Shigeki Ban, Takeki Adachi, Aya Sonezaki, Hiroshi Masuda, Hideki Kamei, Miki Takenaka und 4 weitere

The Kurume Medical Journal · 2023

DOI: 10.2739/kurumemedj.ms7012003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kurume Medical Journal, 2023. Verfasst von Tetsuaki Inokuchi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Kurume Physicians Association (Kurume Naikaikai). Hauptthemen laut MEDLINE: Colchicine, Aspirin, COVID-19 Drug Treatment, COVID-19. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColchicineAspirinCOVID-19 Drug TreatmentCOVID-19HumansMaleFemaleJapanMiddle AgedAdultAdministration, OralDrug Therapy, CombinationHospitalizationSARS-CoV-2Treatment OutcomeAnti-Inflammatory Agents, Non-SteroidalOutpatientsPhenylpropionates

Stichwörter der Autor:innen

COVID-19 (coronavirus disease 2019)alternative therapyaspirincolchicineloxoprofen

Substanzen

ColchicineAspirinloxoprofenAnti-Inflammatory Agents, Non-SteroidalPhenylpropionates

Autor:innen und Institutionen

  • Kurume Physicians Association (Kurume Naikaikai).
  • Inokuchi Clinic.
  • Homma Cardiovascular Clinic.
  • JCHO Kurume General Hospital.
  • Division of Respirology, Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine.
  • Ban Clinic.

Zitieren

APA

Inokuchi, T., Homma, T., Kitasato, Y., Akiyama, M., Chikasue, A., Nishii, Y., Ban, S., Adachi, T., Sonezaki, A., Masuda, H., Kamei, H., Takenaka, M., Tanaka, M., Okamoto, M., Hoshino, T., & K-COCOA (KURUME-COVID-19 THERAPEUTIC PROGRAM BY COLCHICINE AND LOW-DOSE ASPIRIN) STUDY COLLABORATORS (2023). Oral Colchicine and Low-Dose Aspirin Combination Therapy for Non-elderly, Non-severe, Early Time From Onset, Adult Outpatients with Coronavirus Disease 2019 (COVID-19) during “The Fifth Pandemic Wave” in Japan. The Kurume Medical Journal. https://doi.org/10.2739/kurumemedj.ms7012003

Vancouver

Inokuchi T, Homma T, Kitasato Y, Akiyama M, Chikasue A, Nishii Y, et al. Oral Colchicine and Low-Dose Aspirin Combination Therapy for Non-elderly, Non-severe, Early Time From Onset, Adult Outpatients with Coronavirus Disease 2019 (COVID-19) during “The Fifth Pandemic Wave” in Japan. The Kurume Medical Journal. 2023. doi:10.2739/kurumemedj.ms7012003

BibTeX
@article{Inokuchi2023,
  author = {Inokuchi, Tetsuaki and Homma, Tomoki and Kitasato, Yasuhiko and Akiyama, Mayu and Chikasue, Ayako and Nishii, Yuuya and Ban, Shigeki and Adachi, Takeki and Sonezaki, Aya and Masuda, Hiroshi and Kamei, Hideki and Takenaka, Miki and Tanaka, Maki and Okamoto, Masaki and Hoshino, Tomoaki and K-COCOA (KURUME-COVID-19 THERAPEUTIC PROGRAM BY COLCHICINE AND LOW-DOSE ASPIRIN) STUDY COLLABORATORS, K-COCOA (KURUME-COVID-19 THERAPEUTIC PROGRAM BY COLCHICINE AND LOW-DOSE ASPIRIN) STUDY COLLABORATORS},
  title = {Oral Colchicine and Low-Dose Aspirin Combination Therapy for Non-elderly, Non-severe, Early Time From Onset, Adult Outpatients with Coronavirus Disease 2019 (COVID-19) during “The Fifth Pandemic Wave” in Japan},
  journal = {The Kurume Medical Journal},
  year = {2023},
  doi = {10.2739/kurumemedj.ms7012003}
}
Kostenlos starten →